Crystal Structure of Human MMP9 in Complex with a Reverse Hydroxamate Inhibitor
- 1 May 2002
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 319 (1) , 173-181
- https://doi.org/10.1016/s0022-2836(02)00262-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Design and Therapeutic Application of Matrix Metalloproteinase InhibitorsChemical Reviews, 1999
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCirculation, 1999
- The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase InteractionJournal of Biological Chemistry, 1997
- The Helping Hand of Collagenase-3 (MMP-13): 2.7 Å Crystal Structure of its C-terminal Haemopexin-like DomainJournal of Molecular Biology, 1996
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- Identification of 92-kD Gelatinase in Human Coronary Atherosclerotic LesionsCirculation, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.Proceedings of the National Academy of Sciences, 1991
- Partial purification and characterization of a neutral protease which cleaves type IV collagenBiochemistry, 1981